Literature DB >> 23818083

Hemophilia: in review.

Bree Zimmerman1, Leonard A Valentino.   

Abstract

Hemophilia A (deficiency in factor [F] VIII) and hemophilia B (deficiency in FIX) are the most common serious congenital coagulation factor deficiencies. (Based on strong evidence) Hemophilia is a genetic disorder inherited in an Xlinked fashion. Both diseases cause similar bleeding diatheses, with the hallmark being hemarthroses. (Based on strong evidence) The optimal treatment is recombinant factor replacement to prevent bleeding; however, this treatment has many barriers. (Based on strong evidence) The most serious complication of treatment is the development of inhibitors to factor products. (Based on strong evidence) Care for patients with hemophilia is most appropriate in a comprehensive care setting. (Based on strong evidence).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818083     DOI: 10.1542/pir.34-7-289

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  19 in total

1.  The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner.

Authors:  Laura L Swystun; Colleen Notley; Ilinca Georgescu; Jesse D Lai; Kate Nesbitt; Paula D James; David Lillicrap
Journal:  J Thromb Haemost       Date:  2019-03-19       Impact factor: 5.824

2.  FVIII regulates the molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior.

Authors:  Marie Cadé; Javier Muñoz-Garcia; Antoine Babuty; Louis Paré; Denis Cochonneau; Karim Fekir; Mathias Chatelais; Marie-Françoise Heymann; Anna Lokajczyk; Catherine Boisson-Vidal; Dominique Heymann
Journal:  Cell Mol Life Sci       Date:  2022-02-21       Impact factor: 9.261

Review 3.  Consensus recommendations on appropriate coagulation tests during emicizumab administration in Saudi Arabia.

Authors:  Tarek Owaidah; Abdulakareem Almomen; Ahmed Tarawah; Ashraf Warsi; Fawaz Alkasim; Hazzaa Alzahrani; Mahassen Saleh; Ohoud Kashari; Wasil Jastaniah
Journal:  Am J Blood Res       Date:  2022-06-20

4.  Assessing the Performance of Extended Half-Life Coagulation Factor VIII, FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients.

Authors:  Tarek M Owaidah; Hazzaa A Alzahrani; Nouf S Al-Numair; Abdulmjeed O Alnosair; Amelita M Aguilos; Mahasen Saleh
Journal:  Adv Hematol       Date:  2020-09-09

Review 5.  Ankle hemophilic arthropathy: literature review.

Authors:  Tommaso Greco; Chiara Polichetti; Adriano Cannella; Vincenzo La Vergata; Giulio Maccauro; Carlo Perisano
Journal:  Am J Blood Res       Date:  2021-06-15

6.  Left ventricular rotational abnormalities in hemophilia-insights from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study.

Authors:  Attila Nemes; Árpád Kormányos; Péter Domsik; Nóra Ambrus; Nándor Gyenes; Klára Vezendi; Imelda Marton; Zita Borbényi
Journal:  Quant Imaging Med Surg       Date:  2022-02

7.  Clinical and imaging analysis of subclinical hemophilia combined with coxarthrosis: case report and literature review.

Authors:  Cheng Liu; Jun Guo; Qiu Cui; Dingfeng Li; Yanjun Zeng
Journal:  Springerplus       Date:  2016-12-01

8.  First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan.

Authors:  Sayed Hamid Mousavi; Niloofar Khairkhah; Tina Delsouz Bahri; Ali Anvar; Alireza Azizi Saraji; Bita Behnava; Seyed Moayed Alavian; Ali Namvar
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

Review 9.  The role of orthopaedic surgery in haemophilia: current rationale, indications and results.

Authors:  E Carlos Rodríguez-Merchán
Journal:  EFORT Open Rev       Date:  2019-05-10

Review 10.  Microfluidic devices for studying coagulation biology.

Authors:  Brady M Trevisan; Christopher D Porada; Anthony Atala; Graça Almeida-Porada
Journal:  Semin Cell Dev Biol       Date:  2020-06-18       Impact factor: 7.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.